Ali Merhe, MD
Payments from drug & device makers
Across 25 payments — averaging $337.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Boston Scientific$1K
- Photocure Inc$266
- Teleflex LLC$97
- Conmed Corporation$48
- W. L. Gore & Associates, Inc.$37
- plus $54 from 2 others
What the payments were for
- Travel & lodging$2,71032%
- Food & beverage$1,19414%
- Education$3,00036%
- Gifts$230%
- Other$1,50018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $6,876 |
| Boston Scientific | 7 | $1,050 |
| Photocure Inc | 2 | $266 |
| Teleflex LLC | 1 | $97 |
| Conmed Corporation | 1 | $48 |
| W. L. Gore & Associates, Inc. | 1 | $37 |
| 180 Medical, Inc. | 1 | $32 |
| Urogen Pharma, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DA VINCI SP$4,500
- Da Vinci Surgical System$2,298
- Moses 550 D\F\L$865
- Cysview$266
How this compares
$8,428 in reported general payments places this provider in the 65th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 45 | $42,270 |
| Tamsulosin Hcl | 243 | $3,541 |
| Solifenacin Succinate | 27 | $2,129 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 55 | $1,168 |
| Finasteride | 97 | $1,021 |
| Oxybutynin Chloride ErOxybutynin Chloride | 39 | $977 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 15 | $909 |
| Dutasteride | 38 | $861 |
| Trimethoprim | 16 | $559 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $490 |
| Ciprofloxacin Hcl | 106 | $475 |
| Cephalexin | 27 | $396 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 74 | $253 |
| Tramadol Hcl | 83 | $177 |
| Cefdinir | 24 | $166 |
Paid to pharmacies, not to this prescriber.
Other urology in Miami
- Mark Anthony GonzalgoMiami$1.1M
- Chad RitchMiami$796K
- Murugesan ManoharanMiami$262K
- Juan BoletMiami$223K
- Thomas MastersonMiami$189K
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
- Scott SellingerTallahassee$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.